Europe Renal Denervation Market Size & Growth Trends by 2028

Europe Renal Denervation Market Size, Share & Industry Trends Analysis Report By Technology (Radiofrequency, Ultrasound, and Micro-Infusion), By End User, By Product Type By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 78 | Format: PDF | Report ID: KBV-17897

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Europe Renal Denervation Market

Market Report Description

The Europe Renal Denervation Market would witness Market growth of 35.5% CAGR during the forecast period (2022-2028).

Renal denervation minimally invasive operation is proving to be a promising new non-drug treatment option for controlling blood pressure in individuals with resistant hypertension, however, long-term blood pressure control effects of renal denervation for resistant hypertension have yet to be evaluated. Various Market players are focusing on analyzing current long-term follow-up data on the use of renal denervation for RH in order to completely examine the efficiency of renal denervation for RH and to provide practical assistance for practitioners who are setting up a renal denervation service. Moreover, ambulatory blood pressure is a preferred choice for blood pressure measurement.

According to Public Health England data, more than one in every four people in England has high blood pressure. Additionally, as per the data shared by the NHS Digital from the 2019 Health Survey for England, the proportion of males with hypertension grew from 28% to 30% between 2017 and 2018, while rates for women increased from 25% to 26%. Two-thirds of males aged 75 and up have hypertension of some kind. Lack of physical activity, excessive alcohol intake, smoking, and fast food consumption all contribute to an increased risk of hypertension. In addition, various disorders, such as heart attacks, stroke, and pulmonary arterial hypertension, can be caused by high blood pressure.

CE approval has been granted to a significant number of renal denervation devices across the region. Growing R&D initiatives to produce efficient gadgets are a major driver driving the Market 's growth. The introduction of new items in the region would also help the industry to flourish. Rising incidences of drug-resistant hypertension can increase the growth of the Market throughout the forecasting years.

The Germany Market dominated the Europe Renal Denervation Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $92.4 million by 2028. The UK Market is poised to grow at a CAGR of 34.4% during (2022 - 2028). Additionally, The France Market would witness a CAGR of 36.5% during (2022 - 2028).

Based on Technology, the Market is segmented into Radiofrequency, Ultrasound, and Micro-Infusion. Based on End User, the Market is segmented into Hospitals, Specialty Clinics, and Others. Based on Product Type, the Market is segmented into Symplicity, Enlightn, Vessix, Paradise, Iberis, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Renal Denervation Market Size will Hit $1.4 Billion by 2028, at a CAGR of 36.4%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Technology

  • Radiofrequency
  • Ultrasound
  • Micro-Infusion

By End User

  • Hospitals
  • Specialty Clinics
  • Others

By Product Type

  • Symplicity
  • Enlightn
  • Vessix
  • Paradise
  • Iberis
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic PLC
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.
  • Renal Dynamics Limited
  • Johnson & Johnson
  • Terumo Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Renal Denervation Market Report 2022-2028

North America Renal Denervation Market Report 2022-2028

Asia Pacific Renal Denervation Market Report 2022-2028

LAMEA Renal Denervation Market Report 2022-2028

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities